Expert Advice 25 Nov 2020 How to Weather Bad Press as a Biotech Company …sensitive as healthcare. Crises can strike a biotech company at any point — the dream partner company that had shot you to fame dumps you just before your treatment candidate… November 25, 2020 - 7 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 1 Feb 2023 Advancing cancer care with 3D genomics …can often be identified that are universally and uniquely shared across certain diseases. This is because they are highly prevalent binary events, with a high signal-to-noise ratio. This approach is… February 1, 2023 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 8 Nov 2022 Rallybio announces positive phase 1 results for drug treating PNH and gMG …mild or moderate adverse events and no drug-related serious adverse events reported. The ongoing dose escalation study was initiated in February 2022 and is designed to evaluate the safety, pharmacokinetics… November 8, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Aug 2017 And the Winner for the BioPharm America 2017 FREE Ticket Giveaway is… …Bächle, PhD, Outreach Scientist at Addgene P.S. We are planning on teaming up with a few more events, so we can have more giveaways for our awesome readers (that’s you!)… August 16, 2017 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 20 Aug 2020 Is Hepatitis D Healthcare Being Overlooked? …hepatitis B infections and causes scarring and liver cancer much more quickly than any other form of hepatitis. The hepatitis B vaccine prevents hepatitis D. However, for those who get… August 20, 2020 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Apr 2025 Six biotech companies leading the charge in hemophilia treatment …a number of biotech companies developing treatments – from gene therapies to RNAi therapies – for both types of the disorder. In this article, we take a look at six… April 29, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 23 Nov 2022 Tevogen Bio to investigate T cell therapy in long Covid …adverse events. Patients treated were infected with a range of all Covid variants at the time, from Delta through Omicron BA.5. Additionally, each patient had co-morbidities rendering them high risk… November 23, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 30 Mar 2023 Vaccitech announces positive topline data for chronic hepatitis study …completed trial, which included 55 patients with chronic hepatitis B, supported the generally favorable tolerability profile previously reported with VTP-300, with no incidents of VTP-300-related grade 3 adverse events or… March 30, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 2 Nov 2022 Authorization given to BeiGene’s chemo-free treatment option for lymphoma …authorization to biotech company, BeiGene, for Brukinsa (zanubrutinib), which treats adults with the condition who have received at least one prior anti-CD20-based therapy. The approval is applicable to all 27… November 2, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 7 Dec 2022 Rani Therapeutics reveals results from phase 1 osteoporosis study …with no serious adverse events (SAEs) noted during the study. None of the participants withdrew from the repeat-dose study due to any adverse event related to the RaniPill capsule or… December 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Aug 2022 First patient enrolled on Panbela’s trial for treatment of pancreatic cancer …exacerbation of bone marrow suppression and peripheral neuropathy, which can be chemotherapy-related adverse events. Serious visual adverse events have been evaluated and patients with a history of retinopathy or at… August 11, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 May 2025 Nine promising small molecule drug discovery companies to look out for in 2025 …events reported as mild, and no severe or serious adverse events reported. Maze has raised a significant amount of money since it launched with $191 million in 2019; in 2022,… May 16, 2025 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email